| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/31/2012 | CN102757969A Phosphorus transportprotein gene GmPT5 related to phosphorus transport of soybean nodulation and application thereof |
| 10/31/2012 | CN102757958A Construction of CD14 eukaryotic expression vector and method for preparing high-expression cell strain by using CD14 eukaryotic expression vector |
| 10/31/2012 | CN102757491A Method for recycling water-soluble proteins in minced fish rinsing water |
| 10/31/2012 | CN102757490A Chemical synthesis method of hippocampus antimicrobial peptide hkplp and application thereof in breeding industry |
| 10/31/2012 | CN102757489A Method for synchronously extracting and separating arachin and conarrachin |
| 10/31/2012 | CN102757488A Transcription factor for improving plant seed fatty acid content, coding gene and application thereof |
| 10/31/2012 | CN102757487A Plant dwarfing related protein GA2ox, and encoding gene and application thereof |
| 10/31/2012 | CN102757486A Plant development related protein GA20ox, and encoding gene and application thereof |
| 10/31/2012 | CN102757485A Mutant protein of bacillus thuringiensis insecticidal crystal and application thereof |
| 10/31/2012 | CN102757484A HCV (hepatitis C virus) poly-epitope peptide vaccine and application thereof |
| 10/31/2012 | CN102757483A Recombinant adenovirus for expressing porcine teschovirus type 8 VP1 protein and application thereof |
| 10/31/2012 | CN102757474A Method for removing chaotropic agent used in protein preparation process |
| 10/31/2012 | CN102757391A Phenobarbital derivative and preparation method and application thereof |
| 10/31/2012 | CN102755631A Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 10/31/2012 | CN102206653B High quinoline-degrading gene and application thereof |
| 10/31/2012 | CN102002505B Plant high-pH saline-alkaline tolerance gene SucHP and application thereof |
| 10/31/2012 | CN101965199B Selenium containing modifying agents and conjugates |
| 10/30/2012 | US8301398 Structure of the insulin receptor ectodomain |
| 10/30/2012 | US8299324 Insecticidal proteins from Bacillus thuringiensis |
| 10/30/2012 | US8299323 AXMI-010, a delta-endotoxin gene and methods for its use |
| 10/30/2012 | US8299321 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| 10/30/2012 | US8299320 Modulating plant carbon levels |
| 10/30/2012 | US8299229 Mucin antigen vaccine |
| 10/30/2012 | US8299220 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 10/30/2012 | US8299219 Polypeptides, polynucleotides encoding same, antibodies thereagainst and methods of using same for diagnosing and treating cancer and skeletal disorders |
| 10/30/2012 | US8299217 Variant AXMI-R1 delta endotoxin genes and methods for their use |
| 10/30/2012 | US8299213 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 10/30/2012 | US8299212 TDF-related compounds and analogs thereof, analogs and bioactive fragments |
| 10/30/2012 | US8299210 Methods for purifying pertussis toxin and peptides useful therefor |
| 10/30/2012 | US8299209 Pharmaceutical composition comprising cyclic somatostatin analogues |
| 10/30/2012 | US8299045 Adenoviral VA1 Pol III expression system for RNAi expression |
| 10/30/2012 | US8299039 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 10/30/2012 | US8299030 Peptide-based compounds |
| 10/30/2012 | US8299028 Chimeric peptide antagonist for GPCR135 or GPCR142 |
| 10/30/2012 | US8299027 Method of modulating cell survival and reagents useful for same |
| 10/30/2012 | US8299026 Derivatisation of erythropoietin (EPO) |
| 10/30/2012 | US8299022 Analogs of ghrelin substituted at the N-terminal |
| 10/30/2012 | US8299015 Derivatisation of granulocyte colony-stimulating factor |
| 10/30/2012 | US8299013 Clotting and healing compositions containing keratin biomaterials |
| 10/30/2012 | US8298826 Chimaeric vector system |
| 10/30/2012 | US8298821 p185neu-encoding DNA and therapeutical uses thereof |
| 10/30/2012 | US8298816 Expression systems using mammalian beta-actin promoter |
| 10/30/2012 | US8298812 Use of Saccharomyces cerevisiae erg4 mutants for expressing mammalian glucose transporters |
| 10/30/2012 | US8298788 Using transgenic escherichia as bioreactor for producing immunoglobulins specific to streptococcal capsular protein for use in treatment and prevention of bacterial infection |
| 10/30/2012 | US8298782 Reversible MHC multimer staining for functional purification of antigen-specific T cells |
| 10/30/2012 | US8298781 Compositions and methods for characterizing and regulating olfactory sensation |
| 10/30/2012 | US8298777 Method of identifying transmembrane protein-interacting compounds |
| 10/30/2012 | US8298776 Antibodies to tumor associated proteins |
| 10/30/2012 | US8298771 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto |
| 10/30/2012 | US8298770 Methods, kits, and antibodies for detecting parathyroid hormone |
| 10/30/2012 | US8298769 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto |
| 10/30/2012 | US8298551 Streptococcus pyogenes antigens and corresponding DNA fragments |
| 10/30/2012 | US8298541 Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae |
| 10/30/2012 | US8298534 Method of treating fibrproliferative disorders |
| 10/30/2012 | US8298525 Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist |
| 10/30/2012 | US8298524 Methods of using IL-31 to treat chronic obstructive pulmonary disease (COPD) |
| 10/30/2012 | CA2705869C Poxviral oncolytic vectors |
| 10/30/2012 | CA2595038C Modified tie-2 receptor ligands |
| 10/30/2012 | CA2411374C Dual specificity antibodies and methods of making and using |
| 10/30/2012 | CA2375868C Stabilized denatured lipoprotein and method for producing thereof |
| 10/30/2012 | CA2257198C Suppression of specific classes of soybean seed protein genes |
| 10/30/2012 | CA2230111C Antisecretory factor peptides regulating pathological permeability changes |
| 10/30/2012 | CA2215161C Proteinase k resistant surface protein of neisseria meningitidis |
| 10/29/2012 | CA2741110A1 Compositions and methods for determining genetic polymorphisms in the tmem216 gene |
| 10/26/2012 | WO2012145758A1 Fusion peptide designed to reduce plaque bacteria and yeast in the oral cavity |
| 10/26/2012 | WO2012145680A2 Anti-microbial peptides and uses therefore |
| 10/26/2012 | WO2012145676A1 Polypeptides and bacteriophages specific to klebsiella pneumoniae capsular type strains |
| 10/26/2012 | WO2012145666A1 Peptide and conjugate vaccines for fungal infections |
| 10/26/2012 | WO2012145596A1 Filamentous fungi having an altered viscosity phenotype |
| 10/26/2012 | WO2012145595A1 Filamentous fungi having an altered viscosity phenotype |
| 10/26/2012 | WO2012145592A1 Filamentous fungi having an altered viscosity phenotype |
| 10/26/2012 | WO2012145584A1 Filamentous fungi having an altered viscosity phenotype |
| 10/26/2012 | WO2012145539A1 Endoglin polypeptides and uses thereof |
| 10/26/2012 | WO2012145523A2 Aav mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity |
| 10/26/2012 | WO2012145386A1 Methods for isolating and quantifying antigen from vaccines |
| 10/26/2012 | WO2012145384A1 Beta-2 microglobulin-deficient cells |
| 10/26/2012 | WO2012144799A2 Protein skeletal module which increases the binding affinity and binding specificity of active polypeptides |
| 10/26/2012 | WO2012144778A2 Surface-active collagen barrier membrane to which a peptide is bound |
| 10/26/2012 | WO2012144719A1 Surface-active collagen membrane by peptide |
| 10/26/2012 | WO2012143902A1 Compositions relating to a mutant clostridium difficile toxin and methods thereof |
| 10/26/2012 | WO2012143865A1 Plants having enhanced yield-related traits and method for making the same |
| 10/26/2012 | WO2012143862A1 Synthetic phytase variants |
| 10/26/2012 | WO2012143861A1 Synthetic phytase variants |
| 10/26/2012 | WO2012143830A1 Plants having one or more enhanced yield-related traits and method for making the same |
| 10/26/2012 | WO2012143545A1 Methods and means to produce abiotic stress tolerant plants |
| 10/26/2012 | WO2012143543A2 Plants resistant to insect pests |
| 10/26/2012 | WO2012143542A1 Down-regulating gene expression in insect pests |
| 10/26/2012 | WO2012143513A2 Yeast cell capable of converting sugars including arabinose and xylose |
| 10/26/2012 | WO2012143507A1 Novel process for the preparation of a virus-inactivated fv concentrate starting from human plasma, scalable to industrial level |
| 10/26/2012 | WO2012143375A2 Novel hypoallergens |
| 10/26/2012 | WO2012143374A1 Hypoallergen |
| 10/26/2012 | WO2012142970A1 USE OF MODIFIED OsbZIP46 GENE IN CONTROLLING PLANT DROUGHT RESISTANCE |
| 10/26/2012 | WO2012142961A1 Glycoprotein composition with low residual solvent level, and preparation method and use thereof |
| 10/26/2012 | WO2012142921A1 Method for preparing methyl(r)-o-chloromandelate by biocatalytic asymmetric reduction |
| 10/26/2012 | WO2012142706A1 Growth hormone releasing factor (grf) analogs and uses thereof |
| 10/26/2012 | WO2012142696A1 Locally-active anticoagulants and anti-inflammatory agents |
| 10/26/2012 | WO2012142659A1 Site-selective modification of proteins |
| 10/26/2012 | WO2012112767A3 Collagen-targeted nanoparticles |
| 10/26/2012 | WO2012110636A3 Carrier peptides for cell delivery |
| 10/26/2012 | WO2012103240A3 Chimeric il-1 receptor type i agonists and antagonists |